These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38070913)

  • 1. Potential drug-drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study.
    Wondm SA; Tamene FB; Gubae K; Dagnew SB; Worku AA; Belachew EA
    BMJ Open; 2023 Dec; 13(12):e077863. PubMed ID: 38070913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
    Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
    PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
    Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
    BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis.
    Dornquast C; Dombrowski M; Zabel M; Willich SN; Reinhold T
    BMC Health Serv Res; 2020 Mar; 20(1):271. PubMed ID: 32234046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia.
    Dagnew EM; Ergena AE; Wondm SA; Sendekie AK
    BMC Pharmacol Toxicol; 2022 Nov; 23(1):88. PubMed ID: 36447276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
    Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
    Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of prescription medications in home-based older adults with stroke: a pilot study.
    Classen S; Meuleman J; Garvan C; Ried LD; Mann W; Asal N
    Res Social Adm Pharm; 2007 Mar; 3(1):104-22. PubMed ID: 17350560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
    Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
    Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of cancer-related pain management using the Pain Management Index among patients with cancer in the Northwest oncology centres of Ethiopia: an institutional-based cross-sectional study.
    Mihiretie EA; Siyum TS; Tamene FB
    BMJ Open; 2024 Feb; 14(2):e081744. PubMed ID: 38331858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
    Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
    Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
    Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
    J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
    [No Abstract]   [Full Text] [Related]  

  • 14. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential drug-drug interactions in older adults: A population-based study.
    Santos TRA; Silveira EA; Pereira LV; Provin MP; Lima DM; Amaral RG
    Geriatr Gerontol Int; 2017 Dec; 17(12):2336-2346. PubMed ID: 28635169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
    Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
    Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
    Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
    Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
    Noor S; Ismail M; Haider I; Khadim F
    Ann Hepatol; 2018 Oct; 17(6):1001-1011. PubMed ID: 30600298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide prevalence of potential drug-drug interactions associated with non-anticancer agents in patients on oral anticancer agents in South Korea.
    Song YK; Oh JM
    Support Care Cancer; 2020 Aug; 28(8):3711-3720. PubMed ID: 31820128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis.
    Debus JL; Bachmann P; Frahm N; Mashhadiakbar P; Langhorst SE; Streckenbach B; Baldt J; Heidler F; Hecker M; Zettl UK
    Ther Adv Chronic Dis; 2022; 13():20406223221108391. PubMed ID: 35959503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.